BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 9, 2019
View Archived Issues
Zoning affects tumor metabolism
Read More
RASER wire for cancer cells
Read More
Retinoic acid-induced protein 3, a marker of poor outcomes in esophageal cancer patients
Read More
NUP98 predicts poor outcomes in triple-negative breast cancer under anthracycline-based regimens
Read More
Scientists create model of congenital cytomegalovirus transmission after maternal reinfection
Read More
SEECASE trial finds efficacy of NOV-03 in treating dry eye disease
Read More
NEOLEV2 trial highlights the difficulty of treating neonatal seizures
Read More
First clinical data of an ARSB gene therapy for mucopolysaccharidosis type VI
Read More
Neuropore initiates phase I study of NPT-520-34
Read More
Phase I results presented for LY-3154207
Read More
Genetic knockout mice may be an improved model of neuropathic bladder
Read More
FDA allows IND application for phase I study of CB-03-10
Read More
Merck & Co. patents IDO1 inhibitors
Read More
Enrollment completed in second stage of phase II study of bemcentinib plus Keytruda in NSCLC
Read More
Unifying rare diseases may enable multiple treatments
Read More
Shionogi & Co. describes anti-influenza agents
Read More
ObsEva initiates phase III program for linzagolix in endometriosis-associated pain
Read More
IFM Tre discloses NLRP3 inflammasome inhibitors
Read More
First patient dosed in phase II trial of SRK-015 in type 2 and type 3 SMA
Read More
Phase II trial of 15-valent pneumococcal conjugate vaccine V-114 meets primary endpoint
Read More
Provention Bio reports phase Ib results for PRV-300 in ulcerative colitis
Read More
CJ HealthCare identifies JAK1 inhibitors
Read More
FDA clears IND for phase I/II trial of IDE-196 in tumors with GNAQ/11 mutations or PKC fusions
Read More
Texas State University discloses photoactivatable cancer prodrugs
Read More
Oyster Point studies long-term safety of OC-01 nasal spray in ONSET extension trial
Read More
